Mood Stabilizer Medication Adherence in Bipolar Patients During Covid-19 with MMAS-8 Method
DOI:
https://doi.org/10.55324/ijoms.v2i12.647Keywords:
bipolar, mood stabilizer, medication adherence, MMAS-8Abstract
Bipolar is a relapsing disease, a longer duration of treatment is expected to achieve the success of initial therapy. Mood stabilizers are medications to control the mood of people with bipolar disorder. The purpose of the study is to determine adherence to taking mood stabilizer drugs in bipolar patients during the Covid-19 pandemic. The research used descriptive quantitative method with non-probability sampling and the MMAS-8 questionnaire as the instrument. The researchers analyzed data starting from the editing, coding, to processing stages with the help of software. The results of the study show that 21.3% of the drugs used were risperidone. Respondents forgot to take medication as much as 85.3%. Respondents for two weeks did not take medication as much as 78.7%. As many as 60% of respondents had reduced the use of drugs. As many as 72% of respondents have forgotten to bring their medicine when traveling. As many as 81.3% of respondents had taken medicine yesterday. As many as 64% of respondents stopped taking the drug. As many as 77.3% of respondents feel uncomfortable taking medicine every day. As many as 82.7% of respondents had difficulty taking medicine. In conclusion, 87.5% did not comply with taking mood stabilizing drugs during the Covid-19 pandemic and 12.5% ??complied, because during the Covid-19 pandemic, access to control was limited so that it was difficult to get medicine.
References
Andrews, B., & Wilding, J. M. (2004). The relation of depression and anxiety to life-stress and achievement in students. British Journal of Psychology, 95(4). https://doi.org/10.1348/0007126042369802
Anil, M. A., & Bhat, J. S. (2020). Transitional changes in cognitive-communicative abilities in adolescents: A literature review. Journal of Natural Science, Biology and Medicine, 11(2). https://doi.org/10.4103/jnsbm.JNSBM_186_19
Browning, M. H. E. M., Larson, L. R., Sharaievska, I., Rigolon, A., McAnirlin, O., Mullenbach, L., Cloutier, S., Vu, T. M., Thomsen, J., Reigner, N., Metcalf, E. C., D’Antonio, A., Helbich, M., Bratman, G. N., & Alvarez, H. O. (2021). Psychological impacts from COVID-19 among university students: Risk factors across seven states in the United States. PloS One, 16(1). https://doi.org/10.1371/journal.pone.0245327
Dahlgren, M. K., Hooley, J. M., Best, S. G., Sagar, K. A., Gonenc, A., & Gruber, S. A. (2018). Prefrontal cortex activation during cognitive interference in nonsuicidal self-injury. Psychiatry Research - Neuroimaging, 277. https://doi.org/10.1016/j.pscychresns.2018.04.006
Datta, S., Suryadevara, U., & Cheong, J. (2021). Mood disorders. CONTINUUM: Lifelong Learning in Neurology, 27(6).
El-Monshed, A. H., El-Adl, A. A., Ali, A. S., & Loutfy, A. (2022). University students under lockdown, the psychosocial effects and coping strategies during COVID-19 pandemic: A cross sectional study in Egypt. Journal of American College Health, 70(3). https://doi.org/10.1080/07448481.2021.1891086
Elsayed, O. H., Pahwa, M., & El-Mallakh, R. S. (2022). Pharmacologic treatment and management of bipolar disorder in adolescents. Expert Opinion on Pharmacotherapy, 23(10). https://doi.org/10.1080/14656566.2022.2083954
Esaki, Y., Obayashi, K., Saeki, K., Fujita, K., Iwata, N., & Kitajima, T. (2021). Association between circadian activity rhythms and mood episode relapse in bipolar disorder: a 12-month prospective cohort study. Translational Psychiatry, 11(1). https://doi.org/10.1038/s41398-021-01652-9
Grande, I., De Arce, R., Jiménez-Arriero, M. Á., Lorenzo, F. G. I., Valverde, J. I. F., Balanzá-Martínez, V., Zaragoza, S., Cobaleda, S., & Vieta, E. (2013). Patterns of pharmacological maintenance treatment in a community mental health services bipolar disorder cohort study (SIN-DEPRES). International Journal of Neuropsychopharmacology, 16(3). https://doi.org/10.1017/S1461145712000405
Kishi, T., Ikuta, T., Matsuda, Y., Sakuma, K., Okuya, M., Nomura, I., Hatano, M., & Iwata, N. (2022). Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials. Molecular Psychiatry, 27(2). https://doi.org/10.1038/s41380-021-01334-4
Malone, P. M., Schwinghammer, T. L., Kolesar, J. M., Wells, B. G., & DiPiro, J. T. (2016). Pharmacotherapy: Principles & practice (M. A. Chisholm-Burns, Ed.). McGraw-Hill Education.
Marzani, G., & Price Neff, A. (2021). Bipolar Disorders: Evaluation and Treatment. American Family Physician, 103(4).
Mintz, D. (2015). Bipolar Disorder: Overview, Diagnostic Evaluation and Treatment. MD and the Austen Riggs Center.
Moncrieff, J. (2014). The medicalisation of “ups and downs”: ThE marketing of the new bipolar disorder. Transcultural Psychiatry, 51(4). https://doi.org/10.1177/1363461514530024
Padilla-Walker, L. M., & Van der Graaff, J. (2022). Prosocial behavior during adolescence and the transition to adulthood. In APA handbook of adolescent and young adult development. https://doi.org/10.1037/0000298-034
Renaldo, E. (2020, April). Menjaga Kesehatan Mental saat Pandemi Covid-19. Bipolar Care Indonesia.
Rifaya, A., Agustina, R., & Rusli, R. (2019). Pola Penggunaan Obat Mood Stabilizer Pada Pasien Bipolar di Rumah Sakit Jiwa Daerah Atma Husada Mahakam. Proceeding of Mulawarman Pharmaceuticals Conferences, 10. https://doi.org/10.25026/mpc.v10i1.368
Vasudev, A., Macritchie, K., Rao, S. K., Geddes, J., & Young, A. H. (2012). Tiagabine for acute affective episodes in bipolar disorder. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd004694.pub3
Zannah, U., Puspitasari, I. M., & Sinuraya, R. K. (2018). Farmakoterapi Gangguan Bipolar. Farmaka, 16(1).
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Eva Kusumahati, Leni Herliani, Rustiningsih Rustiningsih
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
